Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
WuXi Biologics key operating metrics including Pre-clinical Projects, environmental, and social and governance score (ESG).

Pre-clinical Projects

287
35.4%

H1, 2022

Late-phase Projects

43
34.4%

H1, 2022

Phase I Projects

144
24.1%

H1, 2022

Operating Metrics

MetricsFY, 2019FY, 2020FY, 2021
Pre-clinical Projects121169268
Late-phase Projects162832
Phase I Projects85103119
Phase II Projects273252
Commercial Manufacturing Projects127
Backlog$5.1B$11.3B$13.6B
New Projects59
Service Backlog$1.7B$6.6B$7.9B
Backlog (Upcoming Potential Milestone Fees)$3.4B$4.7B$5.7B
Integrated Projects250334480
Early-phase Projects112135171

Environmental, Social and Governance (ESG)

Overall

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu